LONDON (Alliance News) - Physiomics PLC Monday said it has signed a contract with a new speciality pharmaceuticals customer to investigate how one of the client's new candidate drugs shrinks tumours.
Physiomics scientists will use systems biology approaches to map the possible pathways by which the drug could act, it said in a statement without giving any financial details. The analysis will be used to narrow down possible mechanisms and suggest new experiments that the client can perform to home in on one mechanism.
"If successful, the directors hope that Physiomics will be able to offer its other modelling services to this new client as the project progresses," the company said in a statement.
Physiomics shares were up 31.6% at 0.25 pence early Monday, the biggest gainer on AIM.
By Steve McGrath; stevemcgrath@alliancenews.com; @SteveMcGrath1
Copyright 2013 Alliance News Limited. All Rights Reserved.


(Sharecast News) - Physiomics said on Friday that it was making strong operational progress and building the largest commercial pipeline in its histor...


(Sharecast News) - Physiomics said on Friday that it was making strong operational progress and building the largest commercial pipeline in its histor...


(Alliance News) - Physiomics PLC on Friday said it "continues to make strong operational progress" but noted one-off costs from the dismissal of its p...


(Alliance News) - Physiomics PLC on Tuesday said it traded in line with analyst expectations in its recently completed financial year.Shares in Physio...


(Alliance News) - Medical prediction software developer Physiomics PLC said Monday it has signed an agreement with Nasdaq-listed biopharma firm Bicycl...


(Sharecast News) - Cancer treatment technology provider Physiomics has been awarded a contract by Nasdaq-listed Bicycle Therapeutics, it announced on ...


LONDON (Alliance News) - Physiomics PLC on Tuesday said it has completed its Innovate UK grant project and created a tool that can use routine blood t...


LONDON (Alliance News) - Physiomics PLC on Wednesday said it will use the opportunity of an upcoming conference to meet with current as well as potent...


LONDON (Alliance News) - Physiomics PLC on Thursday reported a narrowed loss for the first half of its current financial year, helped by strong revenu...


(Sharecast News) - Physiomics on Thursday reported a narrowed interim loss after the cancer monitoring technology provider more than doubled its reven...


(Sharecast News) - Physiomics announced on Monday that, following a successful collaboration and pursuant to the master services agreement signed with...